The Week Ahead: What Will December Jobs Data Reveal?
Friday's payroll and unemployment report will show if private-sector job growth continued to slow in December from 2015 levels. Plus, earnings from Walgreens and Constellation Brands.
Friday's payroll and unemployment report will show if private-sector job growth continued to slow in December from 2015 levels. Plus, earnings from Walgreens and Constellation Brands.
For Morningstar, I'm Scott Halver, and welcome to The Week Ahead.
2017 will kick off with some closely watched reports on the health of the employment market and the industrial sector.
The payroll and unemployment report on Friday will reveal if private-sector job growth continued to slow in December from 2015 levels. Morningstar's Bob Johnson says there might not be many reasons to cheer recent employment reports, but that they are strong enough to keep the Fed's rate hike plans on track.
The ISM Index on Tuesday and Friday's factory orders will provide a snapshot of the manufacturing sector. Other economic data includes auto sales and the ISM services gauge.
There won't be much in the way of earnings, but there are a handful of updates due. Walgreens investors will be eyeing pharmacy pricing and the firm's cost-cutting plan on Thursday. They will also be looking for more information on the status of the Rite Aid merger in light of recently announced store divestitures.
Constellation Brands, which also reports on Thursday, has been in focus recently over concerns that changes to trade laws could have a larger impact on the firm given the significant amount of its beer it exports from Mexico to the U.S.
Stay tuned to Morningstar for our take on these stories.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.